Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...
Trump’s Moves to Upend Federal Bureaucracy Touch Off Fear and Confusion Agencies are gripped with uncertainty about how to implement a blizzard of President Trump’s new policies as workers ...